Buscar
Mostrando ítems 151-160 de 4111
Evaluation of pH effects on genomic integrity in adipose-derived mesenchymal stem cells using the comet assay
(Funpec-editora, 2015-01-01)
The use of mesenchymal stem cells (MSCs) in experimental, clinical, and therapeutic trials has grown in recent years. However, the issue remains of whether these procedures are completely safe for transplant patients. ...
Metalloproteinase 2 and 9 Activity Increase in Epicardial Adipose Tissue of Patients with Coronary Artery Disease
(Bentham Science Publishers, 2017-01)
Background: Epicardial adipose tissue (EAT) is a visceral adipose tissue (AT) surrounding and infiltrating myocardium and coronary arteries. Increased EAT may represent a chronic inflammatory injury and a link with coronary ...
Effect of insulin-resistance on circulating and adipose tissue MMP-2 and MMP-9 activity in rats fed a sucrose-rich diet
(Elsevier, 2014-01)
Background and aim: Adipose tissue produces different metalloproteinases (MMPs), involved in adipogenesis and angiogenesis. Different studies have shown that in obesity the behavior of different MMPs may be altered. However ...
White adipose tissue cells and the progression of cachexia: Inflammatory pathways
(2016-05-01)
Background: Cachexia is a systemic syndrome leading to body wasting, systemic inflammation, and to metabolic chaos. It is a progressive condition, and little is known about its dynamics. Detection of the early signs of the ...
Catechin and quercetin attenuate adipose inflammation in fructose‐fed rats and 3T3‐L1 adipocytes
(Wiley, 2015-04)
Scope
This study evaluated the capacity of dietary catechin (C), quercetin (Q), and the combination of both (CQ), to attenuate adipose inflammation triggered by high fructose (HFr) consumption in rats and by tumor necrosis ...
Selective modulation of the CAP/Cbl pathway in the adipose tissue of high fat diet treated rats
(Elsevier Science BvAmsterdamHolanda, 2006)
Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis
(MDPI, 2021-08)
(1) Sodium–glucose cotransporter-2 inhibitors (SGLT2-i) reduce adipose tissue and cardiovascular events in patients with type 2 diabetes (T2D). Accumulation of epicardial adipose tissue (EAT) is associated with increased ...